Download original attachment
(PDF file)

This is an HTML version of an attachment to the Freedom of Information request 'ID 199 from DTA disclosure log'.

From:
Peter Alexander
To:
Corporate Procurement
Subject:
RE: [SEC=OFFICIAL] FOR APPROVAL: Extension of DTA-GEN-325 V1 - Boston Consulting Group
Date:
Monday, 18 May 2020 9:04:19 AM
OFFICIAL
 
Approved.
 
 
OFFICIAL
From: Corporate Procurement <xxxxxxxxx.xxxxxxxxxxx@xxx.xxx.xx> 
Sent: Friday, 15 May 2020 10:32 PM
To: Peter Alexander <xxxxx.xxxxxxxxx@xxx.xxx.xx>
Cc: Corporate Procurement <xxxxxxxxx.xxxxxxxxxxx@xxx.xxx.xx>
Subject: [SEC=OFFICIAL] FOR APPROVAL: Extension of DTA-GEN-325 V1 - Boston Consulting Group
 
OFFICIAL
 
Hi Peter
 
This email seeks your approval under s23(3) of the PGPA Act 2013 and r18 of the PGPA Rule to record
the verbal approval you gave on 8 May 2020 to execute the first option extend with Boston Consulting
Group (ABN 70 007 347 131) for the provision of COVIDSafe app support. Executed change order
attached for your information.
 
The contract details are:
Execution of a 2 week change order with an end date is 22 May 2020.
A 1 month extension option is remains available under the work order.
Initial contract value was $ $484,000 (including GST).
Extension value is $181,500.00 (including GST).
Upper limit on total spend (including extension option) is $665,500 (including GST). 
Cost centre: DT419
 
I confirm process has been conducted in accordance with the Commonwealth Procurement Rules and
DTA’s internal processes.
 
Would be grateful if you could respond to this email with confirmation of your approval.
 
Thanks
 
s 47E(d)
Procurement and Governance Manager
Finance and Business Services Branch
Digital Transformation Agency (DTA)
P:s 47E(d)
www.dta.gov.au
 
The DTA acknowledges the traditional owners of country throughout Australia and their continuing
connection to land, culture and community. We pay our respects to elders past and present


The Boston Consulting Group Pty. Ltd. 
This e-mail message may contain confidential and/or privileged information. If you are not an addressee or
otherwise authorized to receive this message, you should not use, copy, disclose or take any action based on this
e-mail or any information contained in the message. If you have received this material in error, please advise the
sender immediately by reply e-mail and delete this message. 
We may share your contact details with other BCG entities and our third party service providers. Please see
BCG privacy policy https://www.bcg.com/about/privacy-policy.aspx for further information. 
Thank you. 


Document Outline